The First BOT Project Focused on Biotechnology Industry Nationwide - Taipei Biotechnology Park Officially Inaugurated and Operational.
Dignitaries from various sectors, including industry, government, academia, research, medicine, and finance, gathered at the event. Over 30 well-known domestic and international biotechnology companies have established their presence. It is estimated that this developmentwill create more than 3,000 job opportunities and generate an annual output value exceeding 50 billion NTD.
The significant milestone project, 'Taipei Bioinnovation Park,' the first major development focusing on the biotechnology industry cluster in Taiwan, held its grand opening ceremony on March 30th. The event was witnessed by more than 300 prominent guests from both domestic and international sectors, including Taipei City Mayor Chiang Wan-an and Mr. Huang Mao-hsiung, Chairman of Century Biotech Development Co., Ltd. This successful inauguration marks a new chapter in the development of Taiwan's biotechnology industry.
The official opening of Taipei Biotechnology Park will drive the development of the biotechnology industry across Taiwan. The park's strategic location offers three crucial advantages: 'strategic position,' 'convenient transportation,' and 'industry aggregation.' To the south, it is close to prominent biotechnology and pharmaceutical research hubs, such as Academia Sinica and the National Biotechnology Research Park. To the north, it connects with existing medical and IT technology industrial parks. To the west, it neighbors the Food and Drug Administration of the Ministry of Health and Welfare, a major regulatory body for the biomedical industry. Additionally, its proximity to the Nangang Railway Station and integrated transportation hub facilitates rapid connections with other cities and international airports. These strategic advantages are expected to play a crucial role in the future integrated development of the biotechnology and medical industries across Taiwan.
Taipei Biotechnology Park is the first BOT (Build-Operate-Transfer) development project in Taiwan focused on the growth of the biotechnology industry. It combines private sector resources, expertise, and flexible operational strategies, fostering a collaborative effort between the public and private sectors. The project aims to promote the nationwide integration of the biotechnology industry and facilitate international collaborations, acting as a catalyst for the significant advancement of the biotechnology sector. With a land area of over 1.5 hectares, the park features a biotech building constructed by Century Biotech Development with a total floor area of nearly 30,000 ping (approximately 99,150 square meters). The building includes spaces for research, pilot production, and business offices, attracting mid to late-stage technology research or more established biotech enterprises. Additionally, the park offers favorable incentives for nurturing biotechnology companies, assisting in talent development, and providing versatile spaces to fulfill the exhibition and communication needs of biotech companies. It is set to become Taiwan's first comprehensive core base for innovation research, talent development, and international collaboration in the biotechnology industry.
By replicating the successful experience of the Nangang Software Park, Taipei Biotechnology Park has managed to attract over 30 renowned domestic and international biotechnology companies to establish their presence ahead of others. The park's ability to emulate the effective strategies and advantages of the software park has been a key factor in enticing these prominent biotech enterprises to set up their operations in the new biotechnology hub.
Given the crucial significance of biotechnology industry development for Taiwan's future, Century Biotech Development Co., Ltd. has long been cooperating with the government to promote high-tech industry development policies. The company has successfully played a vital role in creating the Nangang Software Park, which has attracted over 400 domestic and international companies, generating a multi-billion NTD output value.
Led by Chairman Huang Mao-hsiung, Century Biotech Development has an excellent management team. With the experience of replicating the success of the Nangang Software Park, the company is once again spearheading the establishment of a core engine for Taiwan's biotechnology industry cluster. This endeavor aims to create a dynamic ecosystem, similar to the Nangang Software Park, as a leading force in shaping the development of Taiwan's biotechnology industry and fostering a hub for biotech enterprises.
During his speech, Chairman Huang Mao-hsiung of Century Biotech Development highlighted the significant attention and anticipation that Taipei Biotechnology Park has garnered since its construction began. Over the past 20 years, he has invested in the development of industrial zones and gained valuable insights from Japan's industrial advancements. Looking ahead, with the completion of the city government's project to connect the National Biotechnology Research Park to Zhongxiao East Road Section 7 through a tunnel, the interconnectivity between the parks will be faster and more convenient, fostering closer industry exchanges and collaborations.
Taipei City Mayor Chiang Wan-an expressed that Nangang serves as a vital hub for the development of the biotechnology industry. It brings together institutions such as the Food and Drug Administration of the Ministry of Health and Welfare, Academia Sinica, National Biotechnology Research Park, Biotech Center, and National Laboratory Animal Center. Through the BOT (Build-Operate-Transfer) project, Taipei Biotechnology Park will be transformed into a multifunctional space encompassing incubation, research, pilot production, and business offices. It is expected to attract over 3,000 job opportunities and drive a biotech annual output value of 50 billion NTD, establishing itself as the new core engine of Taipei's biotechnology industry cluster.
Former Legislative Yuan Speaker and Chairman of the Development Center for Biotechnology, Wang Jin-pyng, stated in his speech that Taipei Biotechnology Park, upon completion, will become a landmark in Nangang with artistic and cultural significance. The Development Center for Biotechnology has previously organized numerous large-scale biotechnology exhibitions and forums. With its future presence in Taipei Biotechnology Park, it will continue to drive the flourishing development of Taiwan's biotechnology industry.
Deputy Minister of Foreign Affairs, Tien Chung-kwang, pointed out that as the first biotechnology BOT project in Taiwan, Taipei Biotechnology Park has attracted various biotech companies from Taiwan, Japan, and the United States. In the future, it is expected to integrate industry and government resources to promote industry innovation, strengthen supply chain collaborations, and seize international market opportunities.
Century Biotech Development Co., Ltd., in collaboration with Taipei City Government, aims to enhance Taiwan's current biotechnology industry development by addressing the urgent needs for pilot production capacity, international connectivity, and industry integration. Through the hardware and software of Taipei Biotechnology Park, the project offers new types of office spaces, laboratories, and small-scale pilot production facilities to continuously serve biotech and high-tech companies. Based on the cluster effect of the existing Nangang Software Park, the project seeks to create a new industrial park to attract both domestic and international corporations to settle in Taipei, increase domestic value, and create employment opportunities for high-end talent, fostering a win-win-win scenario.
Upon its official inauguration, Taipei Biotechnology Park has already attracted a large number of biotechnology and medical enterprises seeking consultations in advance. According to internal statistics from Century Biotech Development Co., Ltd., the number of biotech and medical enterprises expected to move in has already exceeded 30. Among them, the five most prominent categories are 'biopharmaceuticals,' 'cell therapy,' 'biotech services,' 'advanced medical materials,' and 'smart healthcare.' This demonstrates the strong demand for Taipei Biotechnology Park within Taiwan's biotech industry, positioning the biotech industry as one of the crucial development projects to link Taiwan with the global biotech landscape after the ICT industry.
Creating a biotechnology park with an annual output value of 50 billion NTD, generating over 3,000 job opportunities, and serving as an incubator for biotech industry innovation.
Taipei Biotechnology Park is planned to have 17 floors above ground and 3 floors below, covering an area of nearly 28,000 ping (approximately 92,660 square meters). It is designed to be an international-grade biotechnology industrial park, attracting mid to late-stage or more mature biotech enterprises for establishment. The park offers standard floor specifications of 4.5 meters and 6 meters, and special biotech-specific equipment such as power supply, smoke exhaust, ventilation, drainage, and wastewater treatment facilities to enable rapid and efficient occupancy and operation for companies. The park also includes a versatile space of 500 ping (approximately 1,655 square meters) for international conferences and performing arts, providing approximately 350 seats. This high-standard conference hall will serve as a venue for future international meetings and exchange activities. Additionally, to foster cultural and artistic elements, the space can also be utilized for concerts and artistic performances.
The park is committed to contributing to the industry by nurturing new startup companies and biotech talents. A 5,000 ping (approximately 16,550 square meters) innovation incubation center is planned, with an investment of at least two billion NTD to build specialized biotech instruments and equipment. New startup companies will be offered preferential rental programs to access park resources, collaborate with industry partners, and tap into international market opportunities, making the park a hub for innovation in Taiwan's biotech industry.
Furthermore, the surrounding area of the park is thoughtfully planned to create a well-rounded living environment that meets daily needs. Convenient stores, eateries, and other essential services will be available. Together with smart management of the park, this will ensure a comfortable living and working environment for professionals within the park and friendly office spaces for visitors. The completion of the park is expected to generate over 3,000 job opportunities, contribute to an annual output value of 50 billion NTD, stimulate the local economy, and promote regional development.
The inauguration of Taipei Biotechnology Park will inject new momentum into Taiwan's biotech industry. It will attract more outstanding talents and enterprises in the field of biomedical sciences, driving deep collaboration and innovation among industry, government, academia, research, medicine, finance, and other sectors. This advancement will propel Taiwan's biotech industry towards the next milestone.
